Target Name: MIR3170
NCBI ID: G100422881
Other Name(s): mir-3170 | MicroRNA 3170 | microRNA 3170 | hsa-mir-3170 | hsa-miR-3170

MIR3170: A Potential Drug Target and Biomarker

MIR3170, a protein encoded by the gene PLA2L1, is a member of the PLA2 family, which is involved in a variety of cellular processes, including inflammation, fibrosis, and cancer progression. The PLA2 family has been implicated in the development and progression of many diseases, including heart disease, cancer, and neurodegenerative disorders.

MIR3170 has been identified as a potential drug target due to its involvement in the regulation of cellular processes that are associated with the development and progression of many diseases. For example, MIR3170 has been shown to be involved in the regulation of inflammation, fibrosis, and cancer progression. It has also been shown to play a role in the regulation of cellular signaling pathways that are involved in the development of cancer, including the TGF-β pathway.

In addition to its potential as a drug target, MIR3170 has also been identified as a potential biomarker for the diagnosis and treatment of many diseases. For example, MIR3170 has been shown to be involved in the regulation of extracellular matrix (ECM) production, which is involved in the development and progression of many diseases, including cancer. Additionally, MIR3170 has been shown to play a role in the regulation of cell adhesion, which is involved in the development and progression of many diseases, including neurodegenerative disorders.

The identification of MIR3170 as a potential drug target and biomarker has important implications for the development of new treatments for a variety of diseases. By targeting MIR3170 with drugs, researchers may be able to prevent or reverse the development and progression of many diseases, including cancer and neurodegenerative disorders. Additionally, MIR3170 may also be a useful biomarker for the diagnosis of these diseases, allowing for the early detection and treatment of these conditions.

While more research is needed to fully understand the role of MIR3170 in the development and progression of diseases, its potential as a drug target and biomarker is an exciting area of research. As such, the development of new treatments and therapies based on MIR3170 may have a significant impact on the treatment of a wide range of diseases.

Protein Name: MicroRNA 3170

More Common Targets

MIR3171 | MIR3171HG | MIR3173 | MIR3174 | MIR3175 | MIR3176 | MIR3177 | MIR3178 | MIR3179-1 | MIR3179-2 | MIR3179-3 | MIR3180-1 | MIR3180-2 | MIR3180-3 | MIR3180-4 | MIR3180-5 | MIR3182 | MIR3183 | MIR3184 | MIR3185 | MIR3186 | MIR3187 | MIR3188 | MIR3189 | MIR3190 | MIR3191 | MIR3192 | MIR3193 | MIR3194 | MIR3195 | MIR3196 | MIR3197 | MIR3198-1 | MIR3199-1 | MIR3199-2 | MIR31HG | MIR32 | MIR3200 | MIR3201 | MIR3202-1 | MIR3202-2 | MIR320A | MIR320B1 | MIR320B2 | MIR320C1 | MIR320C2 | MIR320D1 | MIR320D2 | MIR320E | MIR323A | MIR323B | MIR324 | MIR325 | MIR325HG | MIR326 | MIR328 | MIR329-1 | MIR329-2 | MIR330 | MIR331 | MIR335 | MIR337 | MIR338 | MIR339 | MIR33A | MIR33B | MIR340 | MIR342 | MIR345 | MIR346 | MIR34A | MIR34AHG | MIR34B | MIR34C | MIR3529 | MIR3591 | MIR3605 | MIR3606 | MIR3609 | MIR361 | MIR3610 | MIR3611 | MIR3612 | MIR3613 | MIR3614 | MIR3615 | MIR3616 | MIR3617 | MIR3618 | MIR3619 | MIR362 | MIR3620 | MIR3621 | MIR3622A | MIR3622B | MIR363 | MIR3646 | MIR3648-1 | MIR3649 | MIR3650